NALIDIXATE SODIUM ANHYDROUS
UNII Y7NU182221

Substance Identification & Data

This profile provides standardized clinical and technical data for Nalidixate Sodium Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y7NU182221.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3374-05-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Y7NU182221

CAS Registry Number

3374-05-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NALIDIXATE SODIUM ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C12H11N2O3.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ROKRAUFZFDQWLE-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

3864541

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c(c(c(C([O-])=O)cn1CC)=O)ccc(n2)C.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nalidixate Sodium Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.